Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

8.6K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies.

International journal of molecular sciences·2026
Same author

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Health Outcomes of Patients with Distal Urea Cycle Disorders Detected by Newborn Screening: Data from the Spanish National Registry.

International journal of neonatal screening·2026
Same author

Natural History of Morquio A Syndrome.

Journal of inherited metabolic disease·2026
Same author

MLH1 promoter methylation, mismatch repair and intestinal differentiation markers in papillary thyroid carcinoma: real-world evidence from Galicia (Northwest Spain).

Virchows Archiv : an international journal of pathology·2026
Same author

AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Oct 30, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

740

Plasma Proteomic Analysis in Morquio A Disease.

José V Álvarez1,2,3, Susana B Bravo4, María Pilar Chantada-Vázquez4

  • 1Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, CIBERER, MetabERN, 15706 Santiago de Compostela, Spain.

International Journal of Molecular Sciences
|July 2, 2021
PubMed
Summary

This study identifies four potential protein biomarkers—fetuin-A, vitronectin, alpha-1-antitrypsin, and clusterin—for Mucopolysaccharidosis type IVA (MPS IVA). These biomarkers may help monitor disease progression and treatment efficacy in MPS IVA patients.

Keywords:
biomarkersenzyme replacement therapylysosomal disordersproteomics

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.9K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.1K

Related Experiment Videos

Last Updated: Oct 30, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

740
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.9K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.1K

Area of Science:

  • Biochemistry
  • Genetics
  • Medical Research

Background:

  • Mucopolysaccharidosis type IVA (MPS IVA) is a genetic lysosomal disorder.
  • It leads to skeletal dysplasia due to the accumulation of keratan sulfate (KS) and chondroitin-6-sulfate.
  • Current enzyme replacement therapy (ERT) shows limited efficacy in bone lesion recovery and growth.

Purpose of the Study:

  • To evaluate existing biomarkers for MPS IVA.
  • To discover novel protein biomarkers for MPS IVA.
  • To assess potential biomarkers for monitoring disease and treatment response.

Main Methods:

  • Proteomics analysis of plasma samples from healthy controls and MPS IVA patients (untreated and ERT-treated).
  • Qualitative and quantitative proteomics approaches were employed.
  • Identification and quantification of 215 proteins comparing different study groups.

Main Results:

  • Four potential protein biomarkers were identified: fetuin-A, vitronectin, alpha-1-antitrypsin, and clusterin.
  • These proteins are implicated in bone and cartilage metabolism.
  • Dysregulated protein levels were observed in MPS IVA patients compared to controls.

Conclusions:

  • Fetuin-A, vitronectin, alpha-1-antitrypsin, and clusterin show promise as novel biomarkers for MPS IVA.
  • Further validation using cartilage and bone samples is necessary.
  • These biomarkers could aid in assessing disease status and therapeutic outcomes.